Human SUMO-3 for enhancing protein expression
US8119369B2 · kind B2 · utility
2Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2005 |
| Grant date | Feb 21, 2012 |
| Priority date | — |
| Expiry date | Jan 23, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/35
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The inventive subject matter relates to novel compositions, methods, and kits for enhancing the expression, solubility, and isolation of heterologous proteins. Further, the inventive subject matter relates to methods for generating proteins with novel N-terminal amino acids, unlike wild-type proteins which always are translated from mRNA with methionine at the N-terminus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.